Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 11, Pages 2806
Publisher
MDPI AG
Online
2021-10-21
DOI
10.3390/cells10112806
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways
- (2021) Yanyan Wang et al. Cells
- From the origin of NASH to the future of metabolic fatty liver disease
- (2021) Andreas Geier et al. GUT
- Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?
- (2021) Amedeo Lonardo Journal of Clinical Medicine
- The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism
- (2021) Charlotte Lefort et al. Cells
- Intestine-specific FXR agonists as potential therapeutic agents for colorectal cancer
- (2021) Yiming Yin et al. BIOCHEMICAL PHARMACOLOGY
- Progress in research on the roles of TGR5 receptor in liver diseases
- (2021) Ke Ma et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- FXR in liver physiology: Multiple faces to regulate liver metabolism
- (2021) Katrin Panzitt et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- A clinical overview of non‐alcoholic fatty liver disease: A guide to diagnosis, the clinical features, and complications—What the non‐specialist needs to know
- (2021) Mark D. Muthiah et al. DIABETES OBESITY & METABOLISM
- Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy
- (2020) John Y. L. Chiang et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Cilofexor, a Nonsteroidal FXR Agonist, in Non‐Cirrhotic Patients with Nonalcoholic Steatohepatitis: A Phase 2 Randomized Controlled Trial
- (2020) Keyur Patel et al. HEPATOLOGY
- Western diet‐induced increase in colonic bile acids compromises epithelial barrier in nonalcoholic steatohepatitis
- (2020) Biki Gupta et al. FASEB JOURNAL
- Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan
- (2020) Ming-Chao Tsai et al. Nutrients
- Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research
- (2020) Amedeo Lonardo et al. Journal of Clinical Medicine
- Blocking sphingosine 1-phosphate receptor 2 accelerates hepatocellular carcinoma progression in a mouse model of NASH
- (2020) Tomoaki Yoshida et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)
- (2020) Stefano Fiorucci et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Multiple Parallel Hits Hypothesis in NAFLD – Revisited After a Decade
- (2020) Herbert Tilg et al. HEPATOLOGY
- Compound 18 Improves Glucose Tolerance in a Hepatocyte TGR5-dependent Manner in Mice
- (2020) Marlena M. Holter et al. Nutrients
- Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition
- (2020) Genta Kakiyama et al. JOURNAL OF LIPID RESEARCH
- Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2
- (2020) Gulibositan Aji et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease
- (2020) Stefan Traussnigg et al. WIENER KLINISCHE WOCHENSCHRIFT
- TGR5 Signaling in Hepatic Metabolic Health
- (2020) Marlena M. Holter et al. Nutrients
- Bile Acids and FXR: Novel Targets for Liver Diseases
- (2020) Mary Stofan et al. Frontiers in Medicine
- Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression
- (2020) Nisreen Nimer et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Alterations in Skin Microbiomes of Patients With Cirrhosis
- (2019) Jasmohan S. Bajaj et al. Clinical Gastroenterology and Hepatology
- Bile Acids as Metabolic Regulators and Nutrient Sensors
- (2019) John Y. L. Chiang et al. Annual Review of Nutrition
- Mitochondrial oxysterol biosynthetic pathway gives evidence for CYP7B1 as controller of regulatory oxysterols
- (2019) Genta Kakiyama et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- S1PR2 antagonist ameliorate high glucose-induced fission and dysfunction of mitochondria in HRGECs via regulating ROCK1
- (2019) Wei Chen et al. BMC Nephrology
- Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications
- (2019) Saumya Jayakumar et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- AKR1D1 and CYP7B1 mutations in patients with inborn errors of bile acid metabolism: Possibly underdiagnosed diseases
- (2019) Ju-Yin Chen et al. Pediatrics and Neonatology
- Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the United States
- (2019) Zobair M. Younossi et al. DIABETES CARE
- The gut-liver axis in liver disease: pathophysiological basis for therapy
- (2019) Agustín Albillos et al. JOURNAL OF HEPATOLOGY
- Regulations of bile acid metabolism in mouse models with hydrophobic bile acid composition
- (2019) Akira Honda et al. JOURNAL OF LIPID RESEARCH
- The influence of biological sex and sex hormones on bile acid synthesis and cholesterol homeostasis
- (2019) Taylor Phelps et al. Biology of Sex Differences
- Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression
- (2019) Aline Gottlieb et al. Cells
- High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw swine
- (2018) M. R. Panasevich et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Animal models to study bile acid metabolism
- (2018) Jianing Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-Induced NASH (DIN) hamster model
- (2018) François Briand et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism
- (2018) Preeti Pathak et al. HEPATOLOGY
- Structural insights into the heterodimeric complex of the nuclear receptors FXR and RXR
- (2018) Weili Zheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Progress and challenges of selective Farnesoid X Receptor modulation
- (2018) Vittoria Massafra et al. PHARMACOLOGY & THERAPEUTICS
- Role of TGR5 (GPBAR1) in Liver Disease
- (2018) Dieter Häussinger et al. SEMINARS IN LIVER DISEASE
- Nonalcoholic Fatty Liver Disease
- (2018) Irene Pierantonelli et al. TRANSPLANTATION
- Sphingosine-1 phosphate promotes intestinal epithelial cell proliferation via S1PR2
- (2017) Huiping Zhou Frontiers in Bioscience-Landmark
- Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
- (2017) Oscar Chávez-Talavera et al. GASTROENTEROLOGY
- Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease
- (2017) Feng Shen et al. Hepatobiliary & Pancreatic Diseases International
- The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice
- (2017) Xiaojiaoyang Li et al. HEPATOLOGY
- The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice
- (2017) Yongqing Wang et al. HEPATOLOGY
- The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
- (2017) Puneet Puri et al. HEPATOLOGY
- Exploring the relationship between nonalcoholic fatty liver disease and pancreatic cancer by computed tomographic survey
- (2017) Chao-Feng Chang et al. Internal and Emergency Medicine
- New trends on obesity and NAFLD in Asia
- (2017) Jian-Gao Fan et al. JOURNAL OF HEPATOLOGY
- Trends in GPCR drug discovery: new agents, targets and indications
- (2017) Alexander S. Hauser et al. NATURE REVIEWS DRUG DISCOVERY
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Clinical relevance of the bile acid receptor TGR5 in metabolism
- (2017) F Samuel van Nierop et al. Lancet Diabetes & Endocrinology
- The Impact of Gut Microbiota on Gender-Specific Differences in Immunity
- (2017) Floris Fransen et al. Frontiers in Immunology
- BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis
- (2017) Adriana Carino et al. Scientific Reports
- Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype?
- (2016) R. J. Hodge et al. DIABETES OBESITY & METABOLISM
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
- (2016) Jérôme Boursier et al. HEPATOLOGY
- Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans
- (2016) Shogo Takahashi et al. JOURNAL OF LIPID RESEARCH
- TGR5, Not Only a Metabolic Regulator
- (2016) Cong Guo et al. Frontiers in Physiology
- Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
- (2016) Marialena Mouzaki et al. PLoS One
- Bile Acids in Physiology, Pathology and Pharmacology
- (2015) Jose J.G. Marin et al. CURRENT DRUG METABOLISM
- Bile acids as metabolic regulators
- (2015) Tiangang Li et al. CURRENT OPINION IN GASTROENTEROLOGY
- Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
- (2015) Amedeo Lonardo et al. DIGESTIVE AND LIVER DISEASE
- Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression
- (2015) Masayuki Nagahashi et al. HEPATOLOGY
- Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
- (2015) Sungsoon Fang et al. NATURE MEDICINE
- TGR5 and Immunometabolism: Insights from Physiology and Pharmacology
- (2015) Alessia Perino et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
- (2015) Changtao Jiang et al. Nature Communications
- Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism
- (2015) Eric Kwong et al. Acta Pharmaceutica Sinica B
- Human steroid and oxysterol 7α-hydroxylase CYP7B1: substrate specificity, azole binding and misfolding of clinically relevant mutants
- (2014) Aleksei V. Yantsevich et al. FEBS Journal
- Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2
- (2014) Runping Liu et al. HEPATOLOGY
- Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
- (2014) Changtao Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation
- (2013) G. Zhang et al. BLOOD
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
- (2013) Sama I. Sayin et al. Cell Metabolism
- Sphingosine-1-phosphate receptor 2
- (2013) Mohamad Adada et al. FEBS Journal
- Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease
- (2012) Hemant Chatrath et al. SEMINARS IN LIVER DISEASE
- TGR5: A Novel Target for Weight Maintenance and Glucose Metabolism
- (2011) Xiaosong Chen et al. Experimental Diabetes Research
- Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes
- (2011) Elaine Studer et al. HEPATOLOGY
- Targeting the TGR5-GLP-1 pathway to combat type 2 diabetes and non-alcoholic fatty liver disease
- (2010) T.W. H. Pols et al. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders
- (2009) Atul Tiwari et al. DRUG DISCOVERY TODAY
- CYP7B1: One Cytochrome P450, Two Human Genetic Diseases, and Multiple Physiological Functions
- (2009) Ashlee R. Stiles et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bile acids: regulation of synthesis
- (2009) John Y. L. Chiang JOURNAL OF LIPID RESEARCH
- Bile acids: Chemistry, physiology, and pathophysiology
- (2009) Maria J Monte et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Sex-specific differences in CYP450 isoforms in humans
- (2008) Marissa J Scandlyn et al. Expert Opinion on Drug Metabolism & Toxicology
- Bile Acids and the Membrane Bile Acid Receptor TGR5—Connecting Nutrition and Metabolism
- (2008) Charles Thomas et al. THYROID
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started